7-148056805-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2384-61313C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.661 in 152,068 control chromosomes in the GnomAD database, including 34,954 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 34952 hom., cov: 32)
Exomes 𝑓: 1.0 ( 2 hom. )

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.268

Publications

7 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.2384-61313C>T intron_variant Intron 15 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.2384-61313C>T intron_variant Intron 15 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1

Frequencies

GnomAD3 genomes
AF:
0.661
AC:
100473
AN:
151948
Hom.:
34895
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.862
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.689
Gnomad ASJ
AF:
0.524
Gnomad EAS
AF:
0.921
Gnomad SAS
AF:
0.558
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.541
Gnomad OTH
AF:
0.618
GnomAD4 exome
AF:
1.00
AC:
4
AN:
4
Hom.:
2
AF XY:
1.00
AC XY:
4
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
1.00
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
2
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.661
AC:
100585
AN:
152064
Hom.:
34952
Cov.:
32
AF XY:
0.662
AC XY:
49208
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.862
AC:
35775
AN:
41498
American (AMR)
AF:
0.690
AC:
10541
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.524
AC:
1817
AN:
3470
East Asian (EAS)
AF:
0.921
AC:
4773
AN:
5182
South Asian (SAS)
AF:
0.559
AC:
2687
AN:
4808
European-Finnish (FIN)
AF:
0.602
AC:
6350
AN:
10554
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.541
AC:
36755
AN:
67950
Other (OTH)
AF:
0.617
AC:
1305
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1649
3298
4947
6596
8245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.605
Hom.:
17907
Bravo
AF:
0.681
Asia WGS
AF:
0.729
AC:
2537
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.84
DANN
Benign
0.63
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2710126; hg19: chr7-147753897; API